This study was conducted to determine the effects of a tablet combining losartan/hydrochlorothiazide (L/HCTZ) in comparison with losartan alone in Japanese diabetic patients with hypertension. Thirty ...
The Kobe combination therapy of losartan plus HCTZ (losartan/HCTZ), effect and safety trial (Kobe-CONNECT) Study was designed to compare the effectiveness and safety of losartan/HCTZ with that of the ...
Silver Spring, MD - The US Food and Drug Administration (FDA) has approved the first generic formulations of losartan potassium tablets, alone (Cozaar, Merck) and in combination with ...
Patients with severe hypertension are at high risk for cardiovascular events. The authors hypothesized that initial treatment with a combination angiotensin receptor blocker/diuretic agent would be ...
Granules India Limited announced today that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Losartan Potassium and Hydrochlorothiazide Tablets ...
Participants assigned losartan/hydrochlorothiazide had a 1-mmol/L increase in two-hour OGTT glucose values at week 12 and a 1.6-mmol/L increase for week 52 (P <.001 for both) compared with ...
The Food and Drug Administration has issued an update on a second expanded voluntary recall of additional lots of potassium salt tablets from Torrent Pharmaceuticals due to unacceptable amounts of an ...
Multiple lots of drugs containing the active ingredient Losartan are being voluntarily recalled by the manufacturers, according to Health Canada, because they might contain a potential human ...
The Food and Drug Administration has once again expanded its recall of widely prescribed blood pressure drugs after trace amounts of a chemical linked to cancer was detected during testing. The latest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback